|
|
 |
|
Viewing report
|
|
|
Alexion Pharmaceuticals Inc (02-Mar-2011)
Directors Deals Ltd, March 2011, Pages: 1
Max Link, (Non-Executive) of Alexion Pharmaceuticals Inc [market cap £5478million] sold 47,637 shares at 95.000USD, holding is now 92,988 shares; representing 0.102 percent of the shares on issue. Holding has decreased 34 percent, the total trade value was £2,807,217 and the significance rating is 78/100.
Directors Deals monitors and analyses share transactions made by directors in the shares of their own company. We monitor 18,000 companies share transactions in 46 countries worldwide (32 in Europe, 7 in Asia, 2 in North America, 2 in Oceania, 2 in the Middle East & 2 in Africa).
|
|
|
|
